Abstract
Crotamine is a rattlesnake-derived toxin that causes fast-twitch muscle paralysis. As a cell-penetrating polypeptide, crotamine has been investigated as an experimental anti-cancer and immunotherapeutic agent. We hypothesized that molecules targeting crotamine could be designed to study its function and intervene in its adverse activities. Here, we characterize synthetic crotamine and show that, like the venom-purified toxin, it induces hindlimb muscle paralysis by affecting muscle contraction and inhibits KCNA3 (Kv1.3) channels. Synthetic crotamine, labeled with a fluorophore, displayed cell penetration, subcellular myofiber distribution, ability to induce myonecrosis, and bind to DNA and heparin. Here, we used this functionally validated synthetic polypeptide to screen a combinatorial phage display library for crotamine-binding cyclic peptides. Selection for tryptophan-rich peptides was observed, binding of which to crotamine was confirmed by ELISA and gel shift assays. One of the peptides (CVWSFWGMYC), synthesized chemically, was shown to bind both synthetic and natural crotamine and to block crotamine-DNA binding. In summary, our study establishes a functional synthetic substitute to the venom-derived toxin and identifies peptides that could further be developed as probes to target crotamine.
Key messages
-
Synthetic crotamine was characterized as a functional substitute for venom-derived crotamine based on myotoxic effects.
-
A combinatorial peptide library was screened for crotamine-binding peptides.
-
Tryptophan-rich peptides were shown to bind to crotamine and interfere with its DNA binding.
-
Crotamine myofiber distribution and affinity for tryptophan-rich peptides provide insights on its mechanism of action.
Similar content being viewed by others
Availability of data and material (data transparency)
The datasets and materials generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability (software application or custom code)
Does not apply.
References
Radis-Baptista G, Kerkis I (2011) Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties. Curr Pharm Des 17:4351–4361
Rizzi CT, Carvalho-de-Souza JL, Schiavon E, Cassola AC, Wanke E, Troncone LR (2007) Crotamine inhibits preferentially fast-twitching muscles but is inactive on sodium channels. Toxicon 50:553–562. https://doi.org/10.1016/j.toxicon.2007.04.026
Koch Hansen L, Sevelsted-Moller L, Rabjerg M, Larsen D, Hansen TP, Klinge L, Wulff H, Knudsen T, Kjeldsen J, Kohler R (2014) Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. J Crohns Colitis 8:1378–1391. https://doi.org/10.1016/j.crohns.2014.04.003
Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, Pennington MW, Hanania NA, Corry DB, Beeton C (2014) Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem 289:12623–12632. https://doi.org/10.1074/jbc.M113.517037
Marinovic MP, Campeiro JD, Lima SC, Rocha AL, Nering MB, Oliveira EB, Mori MA, Hayashi MAF (2018) Crotamine induces browning of adipose tissue and increases energy expenditure in mice. Sci Rep 8:5057. https://doi.org/10.1038/s41598-018-22988-1
Nascimento FD, Hayashi MA, Kerkis A, Oliveira V, Oliveira EB, Radis-Baptista G, Nader HB, Yamane T, Tersariol IL, Kerkis I (2007) Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J Biol Chem 282:21349–21360
Campeiro JD, Marinovic MP, Carapeto FC, Dal Mas C, Monte GG, Carvalho Porta L, Nering MB, Oliveira EB, Hayashi MAF (2018) Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile. Amino Acids 50:267–278. https://doi.org/10.1007/s00726-017-2513-3
Pereira A, Kerkis A, Hayashi MA, Pereira AS, Silva FS, Oliveira EB, Prieto da Silva AR, Yamane T, Radis-Baptista G, Kerkis I (2011) Crotamine toxicity and efficacy in mouse models of melanoma. Expert Opin Investig Drugs 20:1189–1200. https://doi.org/10.1517/13543784.2011.602064
de Carvalho PL, Fadel V, D’Arc Campeiro J, Oliveira EB, Godinho RO, Hayashi MAF (2020) Biophysical and pharmacological characterization of a full-length synthetic analog of the antitumor polypeptide crotamine. J Mol Med 98:1561–1571. https://doi.org/10.1007/s00109-020-01975-y
Mambelli-Lisboa NC, Sciani JM, Brandão Prieto da Silva AR, Kerkis I (2018) Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells. Mol Basel Switz 23. https://doi.org/10.3390/molecules23040968
Chen P-C, Hayashi MAF, Oliveira EB, Karpel RL (2012) DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrier. PLoS ONE 7:e48913. https://doi.org/10.1371/journal.pone.0048913
Kerkis A, Kerkis I, Radis-Baptista G, Oliveira EB, Vianna-Morgante AM, Pereira LV, Yamane T (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. Faseb J 18:1407-+ . https://doi.org/10.1096/fj.03-1459fje
Ponce-Soto LA, Martins-de-Souza D, Marangoni S (2010) Structural and pharmacological characterization of the crotamine isoforms III-4 (MYX4_CROCu) and III-7 (MYX7_CROCu) isolated from the Crotalus durissus cumanensis venom. Toxicon 55:1443–1452. https://doi.org/10.1016/j.toxicon.2010.02.024
Ponce-Soto LA, Martins-de-Souza D, Novello JC, Marangoni S (2007) Structural and biological characterization of two crotamine isoforms IV-2 and IV-3 isolated from the Crotalus durissus cumanensis venom. Protein J 26:533–540. https://doi.org/10.1007/s10930-007-9094-z
Toyama MH, Carneiro EM, Marangoni S, Barbosa RL, Corso G, Boschero AC (2000) Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets. Biochim Biophys Acta 1474:56–60
Toyama MH, Marangoni S, Novello JC, Leite GB, Prado-Franceschi J, da Cruz-Hofling MA, Rodrigues-Simioni L (2003) Biophysical, histopathological and pharmacological characterization of crotamine isoforms F22 and F32. Toxicon 41:493–500
Nedelkov D, Bieber AL (1997) Characterization of the two myotoxin a isomers from the prairie rattlesnake (Crotalus viridis viridis) by capillary zone electrophoresis and fluorescence quenching studies. Toxicon 35:689–698
Aird SD, Kruggel WG, Kaiser II (1991) Multiple myotoxin sequences from the venom of a single prairie rattlesnake (Crotalus viridis viridis). Toxicon 29:265–268
O’Keefe MP, Nedelkov D, Bieber AL, Nieman RA (1996) Evidence for isomerization in myotoxin a from the prairie rattlesnake (Crotalus viridis viridis). Toxicon 34:417–434
Ownby CL, Aird SD, Kaiser I (1988) Physiological and immunological properties of small myotoxins from the venom of the midget faded rattlesnake (Crotalus viridis concolor). Toxicon 26:319–323
Hindi SM, Shin J, Ogura Y, Li H, Kumar A (2013) Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS ONE 8:e72121. https://doi.org/10.1371/journal.pone.0072121
Daquinag AC, Zhang Y, Amaya-Manzanares F, Simmons PJ, Kolonin MG (2011) An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 9:74–86. https://doi.org/10.1016/j.stem.2011.05.017
Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625–632. https://doi.org/10.1038/nm1048
Koivunen EE (1994) Peptides in cell adhesion research. Methods Enzymol 245:346–369
Peigneur S, Orts DJ, Prieto da Silva AR, Oguiura N, Boni-Mitake M, de Oliveira EB, Zaharenko AJ, de Freitas JC, Tytgat J (2012) Crotamine pharmacology revisited: novel insights based on the inhibition of KV channels. Mol Pharmacol 82:90–96. https://doi.org/10.1124/mol.112.078188
Azhdarinia A, Daquinag AC, Tseng C, Ghosh SC, Ghosh P, Amaya-Manzanares F, Sevick-Muraca E, Kolonin MG (2013) A peptide probe for targeted brown adipose tissue imaging. Nat Commun 4:2472. https://doi.org/10.1038/ncomms3472
Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF et al (2011) Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A 108:18637–18642. https://doi.org/10.1073/pnas.1114503108
Nie J, Chang B, Traktuev DO, Sun J, March K, Chan L, Sage EH, Pasqualini R, Arap W, Kolonin MG (2008) IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells Dayt Ohio 26:2735–2745. https://doi.org/10.1634/stemcells.2008-0212
Kolonin MG, Bover L, Sun J, Zurita AJ, Do K-A, Lahdenranta J, Cardó-Vila M, Giordano RJ, Jaalouk DE, Ozawa MG et al (2006) Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res 66:34–40. https://doi.org/10.1158/0008-5472.CAN-05-2748
Kolonin MG, Sun J, Do K-A, Vidal CI, Ji Y, Baggerly KA, Pasqualini R, Arap W (2006) Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J Off Publ Fed Am Soc Exp Biol 20:979–981. https://doi.org/10.1096/fj.05-5186fje
Kolonin MG, Pasqualini R, Arap W (2002) Teratogenicity induced by targeting a placental immunoglobulin transporter. Proc Natl Acad Sci U S A 99:13055–13060. https://doi.org/10.1073/pnas.162468499
Ownby CL, Gutiérrez JM, Colberg TR, Odell GV (1982) Quantitation of myonecrosis induced by myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom. Toxicon 20:877–885
Hayashi MAF, Campeiro JD, Porta LC, Szychowski B, Alves WA, Oliveira EB, Kerkis I, Daniel MC, Karpel RL (2020) Crotamine cell-penetrating nanocarriers: cancer-targeting and potential biotechnological and/or medical applications. Methods Mol Biol 2118:61–89. https://doi.org/10.1007/978-1-0716-0319-2_5
Vu TT, Jeong B, Yu J, Koo BK, Jo SH, Robinson RC, Choe H (2014) Soluble prokaryotic expression and purification of crotamine using an N-terminal maltose-binding protein tag. Toxicon 92:157–165. https://doi.org/10.1016/j.toxicon.2014.10.017
Ziolkowski C, Murchison HA, Bieber AL (1992) Effects of myotoxin alpha on fusion and contractile activity in myoblast-myotube cell cultures. Toxicon 30:397–409
Hayes CE, Bieber AL (1986) The effects of myotoxin from midget faded rattlesnake (Crotalus viridis concolor) venom on neonatal rat myotubes in cell culture. Toxicon 24:169–173
Mebs D, Ehrenfeld M, Samejima Y (1983) Local necrotizing effect of snake venoms on skin and muscle: relationship to serum creatine kinase. Toxicon 21:393–404
Tu AT, Morita M (1983) Attachment of rattlesnake venom myotoxin a to sarcoplasmic reticulum: peroxidase conjugated method. Br J Exp Pathol 64:633–637
Fletcher JE, Hubert M, Wieland SJ, Gong QH, Jiang MS (1996) Similarities and differences in mechanisms of cardiotoxins, melittin and other myotoxins. Toxicon 34:1301–1311
Yudkowsky ML, Beech J, Fletcher JE (1994) Myotoxin a reduces the threshold for calcium-induced calcium release in skeletal muscle. Toxicon 32:273–278
Furukawa K, Funayama K, Ohkura M, Oshima Y, Tu AT, Ohizumi Y (1994) Ca2+ release induced by myotoxin alpha, a radio-labellable probe having novel Ca2+ release properties in sarcoplasmic reticulum. Br J Pharmacol 113:233–239
Ohkura M, Furukawa K, Tu AT, Ohizumi Y (1994) Calsequestrin is a major binding protein of myotoxin alpha and an endogenous Ca2+ releaser in sarcoplasmic reticulum. Eur J Pharmacol 268:R1-2
Ohkura M, Furukawa K, Oikawa K, Ohizumi Y (1995) The properties of specific binding site of 125I-radioiodinated myotoxin a, a novel Ca++ releasing agent, in skeletal muscle sarcoplasmic reticulum. J Pharmacol Exp Ther 273:934–939
Coronado MA, Gabdulkhakov A, Georgieva D, Sankaran B, Murakami MT, Arni RK, Betzel C (2013) Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus. Acta Crystallogr Biol Crystallogr 69:1958–1964. https://doi.org/10.1107/s0907444913018003
Acknowledgements
We thank Alexes Daquinag for phage display training and general support. We would like to thank the Laboratory of Cellular Biology of the Butantan Institute and Alexsander F. Souza for their support in confocal microscopy (Confocal Leica TCS SP8—Project 175 FINEP—IBUINFRA 01.12.0175.00 by Dr. Carlos Jared). We would also like to acknowledge Dener Madeiro de Souza’s help with the cryostat and muscle section preparation.
Funding
Mikhail Kolonin was supported by the Bovay Foundation. Celine Pompeia’s work in this project was funded by the CNPq Conselho Nacional de Desenvolvimento Científico e Tecnológico, Science without Borders Project number 201949/2015–6. The project was also funded by Grant 2015/50040–4, São Paulo Research Foundation (FAPESP) and GlaxoSmithKline. Jan Tytgat was supported by grants G0E7120N, GOC2319N, and GOA4919N (FWO Vlaanderen). Steve Peigneur was supported by grant PDM/19/164 (KU Leuven).
Author information
Authors and Affiliations
Contributions
C.P., I.K., and M.G.K. designed the experiments, analyzed data, and wrote the manuscript; C.P., E.O.F., S.P., J.T., A.P.S., E.B.O., and A. P. performed the experiments, analyzed data, and edited the manuscript.
Ethics declarations
Ethics approval
The animal studies were approved by the Ethical Committee of Animal Use of the Butantan Institute. All procedures for the use and handling of adult female Xenopus laevis frogs (CRB Xénopes, Rennes, France) were approved by the Animal Ethics Committee of the KU Leuven (Project No. P186/2019) following regulations of the European Union (EU) concerning the welfare of laboratory animals as declared in Directive 2010/63/EU.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 27077 KB)
Rights and permissions
About this article
Cite this article
Pompeia, C., Frare, E.O., Peigneur, S. et al. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. J Mol Med 100, 65–76 (2022). https://doi.org/10.1007/s00109-021-02140-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-021-02140-9